| Levodopa and the progression of Parkinson's disease Parkinson Study Group New England Journal of Medicine 351 (24), 2498-2508, 2004 | 2358 | 2004 |
| A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study Parkinson Study Group Archives of Neurology 59 (12), 1937-1943, 2002 | 701 | 2002 |
| High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor W Koller, R Pahwa, K Busenbark, J Hubble, S Wilkinson, A Lang, P Tuite, ... Annals of Neurology: Official Journal of the American Neurological …, 1997 | 619 | 1997 |
| Proprioception and motor control in Parkinson's disease J Konczak, DM Corcos, F Horak, H Poizner, M Shapiro, P Tuite, ... Journal of motor behavior 41 (6), 543-552, 2009 | 414 | 2009 |
| Adenosine A2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002 … PA LeWitt, M Guttman, JW Tetrud, PJ Tuite, A Mori, P Chaikin, ... Annals of neurology 63 (3), 295-302, 2008 | 407 | 2008 |
| Entacapone improves motor fluctuations in levodopa-treated Parkinson's disease patients Parkinson Study Group Ann. Neurol. 42, 747-755, 1997 | 402 | 1997 |
| Hypertrophic olivary degeneration: metaanalysis of the temporal evolution of MR findings M Goyal, E Versnick, P Tuite, J Saint Cyr, W Kucharczyk, W Montanera, ... American Journal of Neuroradiology 21 (6), 1073-1077, 2000 | 325 | 2000 |
| A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ... JAMA neurology 71 (5), 543-552, 2014 | 308 | 2014 |
| A controlled trial of rotigotine monotherapy in early Parkinson's disease Parkinson Study Group Archives of neurology 60 (12), 1721-1728, 2003 | 276 | 2003 |
| Dysfunction of the basal ganglia, but not the cerebellum, impairs kinaesthesia M Maschke, CM Gomez, PJ Tuite, J Konczak Brain 126 (10), 2312-2322, 2003 | 274 | 2003 |
| Paraneoplastic chorea associated with CRMP‐5 neuronal antibody and lung carcinoma S Vernino, P Tuite, CH Adler, JF Meschia, BF Boeve, P Boasberg, ... Annals of neurology 51 (5), 625-630, 2002 | 251 | 2002 |
| Altered diffusion in the frontal lobe in Parkinson disease ATK Kendi, S Lehericy, M Luciana, K Ugurbil, P Tuite American Journal of Neuroradiology 29 (3), 501-505, 2008 | 249 | 2008 |
| N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases MJ Holmay, M Terpstra, LD Coles, U Mishra, M Ahlskog, G Öz, JC Cloyd, ... Clinical neuropharmacology 36 (4), 103-106, 2013 | 234 | 2013 |
| Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS UE Emir, PJ Tuite, G Öz PloS one 7 (1), e30918, 2012 | 217 | 2012 |
| Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts S Michaeli, G Oez, DJ Sorce, M Garwood, K Ugurbil, S Majestic, P Tuite Movement disorders: official journal of the Movement Disorder Society 22 (3 …, 2007 | 192 | 2007 |
| The evaluation and management of patients with neuroleptic malignant syndrome MJ Bhanushali, PJ Tuite Neurologic Clinics 22 (2), 389-411, 2004 | 166 | 2004 |
| Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification SC Hsu, RL Sears, RR Lemos, B Quintáns, A Huang, E Spiteri, L Nevarez, ... Neurogenetics 14, 11-22, 2013 | 165 | 2013 |
| Progressive ataxia and palatal tremor (PAPT) Clinical and MRI assessment with review of palatal tremors M Samuel, N Torun, PJ Tuite, JA Sharpe, AE Lang Brain 127 (6), 1252-1268, 2004 | 164 | 2004 |
| Interval timing and Parkinson’s disease: heterogeneity in temporal performance H Merchant, M Luciana, C Hooper, S Majestic, P Tuite Experimental brain research 184, 233-248, 2008 | 160 | 2008 |
| Repeated‐dose oral N‐acetylcysteine in Parkinson's disease: pharmacokinetics and effect on brain glutathione and oxidative stress LD Coles, PJ Tuite, G Öz, UR Mishra, RV Kartha, KM Sullivan, JC Cloyd, ... The Journal of Clinical Pharmacology 58 (2), 158-167, 2018 | 153 | 2018 |
Jürgen Konczak PhDProfessor of Movement Neuroscience and Biomechanics, University of Minnesota, U.S.A.Email verificata su umn.edu
